Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy

Abstract Cones are responsible for daylight, central, high acuity and color vision. Three proteins found in human cones, i.e. long-wavelength (L)-, middle-wavelength (M)-, and short-wavelength sensitive (S)-opsins, are responsible for red, green and blue color recognition, respectively. Human blue c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuxin Zhang, Wen-Tao Deng, Wei Du, Ping Zhu, Jie Li, Fan Xu, Jingfen Sun, Cecilia D. Gerstner, Wolfgang Baehr, Sanford L. Boye, Chen Zhao, William W. Hauswirth, Ji-jing Pang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bc27d7c6a496437cb3861b2557b98e8d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc27d7c6a496437cb3861b2557b98e8d
record_format dspace
spelling oai:doaj.org-article:bc27d7c6a496437cb3861b2557b98e8d2021-12-02T16:06:15ZGene-based Therapy in a Mouse Model of Blue Cone Monochromacy10.1038/s41598-017-06982-72045-2322https://doaj.org/article/bc27d7c6a496437cb3861b2557b98e8d2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06982-7https://doaj.org/toc/2045-2322Abstract Cones are responsible for daylight, central, high acuity and color vision. Three proteins found in human cones, i.e. long-wavelength (L)-, middle-wavelength (M)-, and short-wavelength sensitive (S)-opsins, are responsible for red, green and blue color recognition, respectively. Human blue cone monochromacy (BCM) is characterized by functional loss of both L- and M-cone opsins due to mutations in the OPN1LW/OPN1MW gene cluster on the X chromosome. BCM patients, who rely on their vision from only S-cones and rods, suffer severely reduced visual acuity and impaired color vision. Recent studies show that there is sufficient cone structure remaining in the central fovea of BCM patients to consider AAV-mediated gene augmentation therapy. In contrast, mouse retina has only two opsins, S-opsin and M-opsin, but no L-opsin. We generated an M-opsin knockout mouse (Opn1mw −/−) expressing only S-opsin as a model for human BCM. We show that recombinant M-opsin delivered by AAV5 vectors rescues M-cone function in Opn1mw −/− mice. We also show that AAV delivered M-opsin localizes in the dorsal cone outer segments, and co-localizes with S-opsin in the ventral retina. Our study demonstrates that cones without M-opsin remain viable and respond to gene augmentation therapy, thereby providing proof-of-concept for cone function restoration in BCM patients.Yuxin ZhangWen-Tao DengWei DuPing ZhuJie LiFan XuJingfen SunCecilia D. GerstnerWolfgang BaehrSanford L. BoyeChen ZhaoWilliam W. HauswirthJi-jing PangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yuxin Zhang
Wen-Tao Deng
Wei Du
Ping Zhu
Jie Li
Fan Xu
Jingfen Sun
Cecilia D. Gerstner
Wolfgang Baehr
Sanford L. Boye
Chen Zhao
William W. Hauswirth
Ji-jing Pang
Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
description Abstract Cones are responsible for daylight, central, high acuity and color vision. Three proteins found in human cones, i.e. long-wavelength (L)-, middle-wavelength (M)-, and short-wavelength sensitive (S)-opsins, are responsible for red, green and blue color recognition, respectively. Human blue cone monochromacy (BCM) is characterized by functional loss of both L- and M-cone opsins due to mutations in the OPN1LW/OPN1MW gene cluster on the X chromosome. BCM patients, who rely on their vision from only S-cones and rods, suffer severely reduced visual acuity and impaired color vision. Recent studies show that there is sufficient cone structure remaining in the central fovea of BCM patients to consider AAV-mediated gene augmentation therapy. In contrast, mouse retina has only two opsins, S-opsin and M-opsin, but no L-opsin. We generated an M-opsin knockout mouse (Opn1mw −/−) expressing only S-opsin as a model for human BCM. We show that recombinant M-opsin delivered by AAV5 vectors rescues M-cone function in Opn1mw −/− mice. We also show that AAV delivered M-opsin localizes in the dorsal cone outer segments, and co-localizes with S-opsin in the ventral retina. Our study demonstrates that cones without M-opsin remain viable and respond to gene augmentation therapy, thereby providing proof-of-concept for cone function restoration in BCM patients.
format article
author Yuxin Zhang
Wen-Tao Deng
Wei Du
Ping Zhu
Jie Li
Fan Xu
Jingfen Sun
Cecilia D. Gerstner
Wolfgang Baehr
Sanford L. Boye
Chen Zhao
William W. Hauswirth
Ji-jing Pang
author_facet Yuxin Zhang
Wen-Tao Deng
Wei Du
Ping Zhu
Jie Li
Fan Xu
Jingfen Sun
Cecilia D. Gerstner
Wolfgang Baehr
Sanford L. Boye
Chen Zhao
William W. Hauswirth
Ji-jing Pang
author_sort Yuxin Zhang
title Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
title_short Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
title_full Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
title_fullStr Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
title_full_unstemmed Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
title_sort gene-based therapy in a mouse model of blue cone monochromacy
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/bc27d7c6a496437cb3861b2557b98e8d
work_keys_str_mv AT yuxinzhang genebasedtherapyinamousemodelofblueconemonochromacy
AT wentaodeng genebasedtherapyinamousemodelofblueconemonochromacy
AT weidu genebasedtherapyinamousemodelofblueconemonochromacy
AT pingzhu genebasedtherapyinamousemodelofblueconemonochromacy
AT jieli genebasedtherapyinamousemodelofblueconemonochromacy
AT fanxu genebasedtherapyinamousemodelofblueconemonochromacy
AT jingfensun genebasedtherapyinamousemodelofblueconemonochromacy
AT ceciliadgerstner genebasedtherapyinamousemodelofblueconemonochromacy
AT wolfgangbaehr genebasedtherapyinamousemodelofblueconemonochromacy
AT sanfordlboye genebasedtherapyinamousemodelofblueconemonochromacy
AT chenzhao genebasedtherapyinamousemodelofblueconemonochromacy
AT williamwhauswirth genebasedtherapyinamousemodelofblueconemonochromacy
AT jijingpang genebasedtherapyinamousemodelofblueconemonochromacy
_version_ 1718385049534988288